Your browser doesn't support javascript.
Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial.
Blair, Peter S; Young, Grace; Clement, Clare; Dixon, P; Seume, Penny; Ingram, Jenny; Taylor, Jodi; Cabral, Christie; Lucas, Patricia J; Beech, Elizabeth; Horwood, Jeremy; Gulliford, Martin; Francis, Nick A; Creavin, Sam; Lane, Janet A; Bevan, Scott; Hay, Alastair D.
  • Blair PS; Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK p.s.blair@bris.ac.uk.
  • Young G; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Clement C; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Dixon P; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Seume P; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
  • Ingram J; Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK.
  • Taylor J; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Cabral C; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
  • Lucas PJ; School for Policy Studies, University of Bristol, Bristol, UK.
  • Beech E; NHS England and NHS Improvement South West, Bath, UK.
  • Horwood J; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
  • Gulliford M; King's College London, School of Population and Life Course Sciences London, UKPrimary Care Research Centre, School of Primary Care Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Creavin S; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
  • Lane JA; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Bevan S; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Hay AD; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
BMJ ; 381: e072488, 2023 04 26.
Article in English | MEDLINE | ID: covidwho-2292342
ABSTRACT

OBJECTIVE:

To assess whether an easy-to-use multifaceted intervention for children presenting to primary care with respiratory tract infections would reduce antibiotic dispensing, without increasing hospital admissions for respiratory tract infection.

DESIGN:

Two arm randomised controlled trial clustered by general practice, using routine outcome data, with qualitative and economic evaluations.

SETTING:

English primary care practices using the EMIS electronic medical record system.

PARTICIPANTS:

Children aged 0-9 years presenting with respiratory tract infection at 294 general practices, before and during the covid-19 pandemic. INTERVENTION Elicitation of parental concerns during consultation; a clinician focused prognostic algorithm to identify children at very low, normal, or elevated 30 day risk of hospital admission accompanied by antibiotic prescribing guidance; and a leaflet for carers including safety netting advice. MAIN OUTCOME

MEASURES:

Rate of dispensed amoxicillin and macrolide antibiotics (superiority comparison) and hospital admissions for respiratory tract infection (non-inferiority comparison) for children aged 0-9 years over 12 months (same age practice list size as denominator).

RESULTS:

Of 310 practices needed, 294 (95%) were randomised (144 intervention and 150 controls) representing 5% of all registered 0-9 year olds in England. Of these, 12 (4%) subsequently withdrew (six owing to the pandemic). Median intervention use per practice was 70 (by a median of 9 clinicians). No evidence was found that antibiotic dispensing differed between intervention practices (155 (95% confidence interval 138 to 174) items/year/1000 children) and control practices (157 (140 to 176) items/year/1000 children) (rate ratio 1.011, 95% confidence interval 0.992 to 1.029; P=0.25). Pre-specified subgroup analyses suggested reduced dispensing in intervention practices with fewer prescribing nurses, in single site (compared with multisite) practices, and in practices located in areas of lower socioeconomic deprivation, which may warrant future investigation. Pre-specified sensitivity analysis suggested reduced dispensing among older children in the intervention arm (P=0.03). A post hoc sensitivity analysis suggested less dispensing in intervention practices before the pandemic (rate ratio 0.967, 0.946 to 0.989; P=0.003). The rate of hospital admission for respiratory tract infections in the intervention practices (13 (95% confidence interval 10 to 18) admissions/1000 children) was non-inferior compared with control practices (15 (12 to 20) admissions/1000 children) (rate ratio 0.952, 0.905 to 1.003).

CONCLUSIONS:

This multifaceted antibiotic stewardship intervention for children with respiratory tract infections did not reduce overall antibiotic dispensing or increase respiratory tract infection related hospital admissions. Evidence suggested that in some subgroups and situations (for example, under non-pandemic conditions) the intervention slightly reduced prescribing rates but not in a clinically relevant way. TRIAL REGISTRATION ISRCTN11405239ISRCTN registry ISRCTN11405239.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / COVID-19 Type of study: Experimental Studies / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adolescent / Child / Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2023 Document Type: Article Affiliation country: Bmj-2022-072488

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / COVID-19 Type of study: Experimental Studies / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adolescent / Child / Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2023 Document Type: Article Affiliation country: Bmj-2022-072488